← Leaderboards
Fu-Tong Liu
Scripps Research Institute
$7,460,724
Attributed
$7,996,513
Total exposure
17
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $834.8K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$8,796,457 · 18
By mechanism
R01$5,736,323 · 4
U19$925,613 · 2
R43$803,683 · 1
R21$653,129 · 2
T32$489,569 · 1
P51$126,398 · 2
Top collaborators
- Swey-Shen Chen2 shared
- Daniel K Hsu2 shared
Most similar at Scripps Research Institute
Same institution · by research overlap
- James C. Paulson$35,883,499
- Qi Yan$47,044
Others in their field
Top investigators on “Lectin”
- Jamey Marth · Sanford Burnham Prebys Medical Discovery Institute$18,947,876
- James C. Paulson · Scripps Research Institute$18,783,747
- Richard D Cummings · University Of Oklahoma Hlth Sciences Ctr$16,973,403
- Michael Demetriou · University Of California-Irvine$15,170,531
- Jay Evans · Corixa Corporation$13,735,700
- Gregory L Stahl · Brigham And Women'S Hospital$13,413,501
Research focus
LectinInflammationLaboratory MouseHuman SubjectGalactosidesAtopic DermatitisClinical ResearchDisease /Disorder ModelImmunoglobulin EMast CellGalectin 3FamilyAffinityGalactose Binding LectinProteinsAmino Acid SequenceEosinophilMemberIn VivoCellsConsensusBinding (Molecular Function)PlayProtein Structure Function
Grant awards (44)
Galectin-3 in regulation of allergic skin inflammation$324,311
R01 · FY2014 · AR · contact PI
Galectin-3 in regulation of allergic skin inflammation$314,384
R01 · FY2013 · AR · contact PI
Galectin-3 in regulation of allergic skin inflammation$330,930
R01 · FY2012 · AR · contact PI
Galectin-3 in regulation of allergic skin inflammation$330,930
R01 · FY2011 · AR · contact PI
DEVELOPMENT OF NONHUMAN PRIMATE MODELS OF ATOPIC DERMATITIS$50,419
P51 · FY2011 · RR · contact PI
Targeting Galectin-3 with novel drugs for treatment of eczema$402,036
R43 · FY2010 · AI
Galectin-3 in regulation of allergic skin inflammation$356,756
R01 · FY2010 · AR · contact PI
DEVELOPMENT OF NONHUMAN PRIMATE MODELS OF ATOPIC DERMATITIS$75,979
P51 · FY2010 · RR · contact PI
Targeting Galectin-3 with novel drugs for treatment of eczema$401,647
R43 · FY2009 · AI
Galectins and Innate Immunity$276,259
R01 · FY2008 · AI · contact PI
Regulation of Skin Wound Epithelialization by Galectin-3$160,132
R21 · FY2008 · AR · contact PI
Galectins and Innate Immunity$281,609
R01 · FY2007 · AI · contact PI
Regulation of Skin Wound Epithelialization by Galectin-3$196,080
R21 · FY2007 · AR · contact PI
Galectins and Innate Immunity$290,021
R01 · FY2006 · AI · contact PI
Galectins and Innate Immunity$297,000
R01 · FY2005 · AI
GALECTINS IN ALLERGIC INFLAMMATION$222,750
R01 · FY2005 · AI
Galectins and Innate Immunity$297,000
R01 · FY2004 · AI
GALECTINS IN ALLERGIC INFLAMMATION$222,750
R01 · FY2004 · AI
IMMUNOLOGIC BASIS OF ANTI-IGE THERAPY$7,020
M01 · FY2004 · RR
Immunological Basis of Anti-IgE Therapy$291,130
R01 · FY2003 · AI
GALECTINS IN ALLERGIC INFLAMMATION$222,750
R01 · FY2003 · AI
Validation of Galectin-3 as a Target in Cancer Therapy$148,500
R21 · FY2003 · CA
Immunological Basis of Anti-IgE Therapy$291,073
R01 · FY2002 · AI
GALECTINS IN ALLERGIC INFLAMMATION$222,500
R01 · FY2002 · AI
Validation of Galectin-3 as a Target in Cancer Therapy$148,417
R21 · FY2002 · CA
IGE BINDING PROTEIN IN PATIENTS W/ ALLERGIC DISEASE$0
M01 · FY2002 · RR
DEVELOPING AN ANIMAL MODEL FOR ATOPIC DERMATITIS$0
M01 · FY2002 · RR
CORE--ANIMAL$0
P01 · FY2002 · AI
GALECTINS IN PATHOGENESIS OF ASTHMA: CHEMOTACTIC EFFECTS$0
P01 · FY2002 · AI
HUMAN GALECTIN 9 AS A NOVEL EOSINOPHIL CHEMOATTRACTANT$0
M01 · FY2002 · RR
Immunological Basis of Anti-IgE Therapy$348,346
R01 · FY2001 · AI
GALECTINS IN ALLERGIC INFLAMMATION$282,000
R01 · FY2001 · AI
TRAINING IN MOLECULAR AND CELL BIOLOGY OF ALLERGY$257,431
T32 · FY2001 · AI
GALECTIN 3 IN REGULATION OF CELL GROWTH AND APOPTOSIS$231,616
R01 · FY2001 · AI
GALECTIN 3 IN REGULATION OF CELL GROWTH AND APOPTOSIS$44,362
R01 · FY2001 · AI
GALECTINS IN PATHOGENESIS OF ASTHMA: CHEMOTACTIC EFFECTS$0
P01 · FY2001 · AI
CORE--ANIMAL$0
P01 · FY2001 · AI
SIGNALING IN ALLERGIC INFLAMMATION$799,944
U19 · FY2000 · AI
GALECTIN 3 IN REGULATION OF CELL GROWTH AND APOPTOSIS$257,846
R01 · FY2000 · AI
TRAINING IN MOLECULAR AND CELL BIOLOGY OF ALLERGY$232,138
T32 · FY2000 · AI
REGULATORY ROLE OF FC(EPSILON)RI IN ALLERGIC INFLAMMATION$125,669
U19 · FY2000 · AI
IGE BINDING PROTEIN IN PATIENTS W/ ALLERGIC DISEASE$27,361
M01 · FY2000 · RR
DEVELOPING AN ANIMAL MODEL FOR ATOPIC DERMATITIS$27,361
M01 · FY2000 · RR
HUMAN GALECTIN 9 AS A NOVEL EOSINOPHIL CHEMOATTRACTANT$0
M01 · FY2000 · RR